Solosec (Secnidazole) Shortage Update: What Patients Need to Know in 2026

If you've been prescribed Solosec (secnidazole) for bacterial vaginosis or trichomoniasis and your pharmacy told you it's out of stock, you might be wondering if there's an official shortage. Here's an honest, up-to-date look at what's happening with Solosec availability in 2026.

Is Solosec Officially in Shortage in 2026?

As of 2026, Solosec (secnidazole) is not listed on the FDA's Drug Shortage Database. This means there is no manufacturer-declared, nationwide shortage. However, that official status doesn't tell the full story. Patients across the country continue to report difficulty filling their Solosec prescriptions — pharmacies frequently have no stock, and some patients are waiting multiple days before finding a location that can fill their prescription.

The FDA shortage database only captures drugs where manufacturers have officially notified the FDA of production interruptions. Local stocking gaps, distributor decisions, and insurance-related demand fluctuations don't appear on that list — but they create real access problems for patients.

Why Is Solosec Hard to Find Even Without an Official Shortage?

Single manufacturer: Lupin Pharmaceuticals is the sole producer of Solosec in the U.S. Any disruption in their manufacturing, packaging, or distribution pipeline affects availability nationwide.

No generic competition: Without a generic version on the market, there is no backup supply. Most other common antibiotics have multiple generic manufacturers.

Limited stocking at pharmacies: Because Solosec is a relatively low-volume, high-cost medication, many pharmacies keep only a handful of packets on hand. Even a small uptick in demand can lead to a local stockout.

Insurance step therapy requirements: Insurance barriers mean demand fluctuates unpredictably. When insurers approve more prescriptions after prior auth, multiple patients may flood a local pharmacy's inventory simultaneously.

Current Solosec Availability Outlook for 2026

Solosec remains on the market and is being manufactured and distributed. If you can't find it at your first or second pharmacy, that's a stocking gap — not necessarily a widespread shortage. With some effort (or by using tools like medfinder), most patients in metropolitan and suburban areas can locate a pharmacy that has it. Rural patients may experience longer delays.

The bigger ongoing challenge is cost. Even when pharmacies have Solosec in stock, the retail price ranges from $290 to $550 per single packet. This creates a practical access barrier for uninsured or underinsured patients.

What Should You Do If You Can't Find Solosec?

Use medfinder: medfinder contacts pharmacies in your area to find which ones can fill your prescription. Text results are sent directly to your phone.

Call multiple pharmacies: Try CVS, Walgreens, Walmart Pharmacy, and local independent pharmacies. Availability can differ dramatically between locations in the same city.

Use the manufacturer savings card: If cost is the barrier, the Solosec copay card can reduce costs to as little as $25 (insured) or $75 (cash pay). Visit solosec.com.

Ask your doctor about alternatives: Metronidazole is the CDC's first-line alternative for both BV and trichomoniasis — widely available for $4–$15. Tinidazole is another effective option.

39,448+ patients found their medications in stock

39K+

Find Secnidazole In Stock Today →

Will There Be a Solosec Generic Soon?

As of 2026, the FDA has not approved a generic version of Solosec (secnidazole). Generic drug approvals in the U.S. depend on patent expiration and successful Abbreviated New Drug Applications (ANDAs). While the Solosec patent situation could open the door for generics in the future, no approved generic is currently available. If and when a generic is approved, it would significantly improve access and reduce prices.

For practical next steps, see our guide on how to find Solosec in stock near you.